Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Phyllodes tumours of the breast: a consensus review.

Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, Calvo JP, Dabbs DJ, Ellis IO, Eusebi V, Farshid G, Fox SB, Ichihara S, Lakhani SR, Rakha EA, Reis-Filho JS, Richardson AL, Sahin A, Schmitt FC, Schnitt SJ, Siziopikou KP, Soares FA, Tse GM, Vincent-Salomon A, Tan PH.

Histopathology. 2016 Jan;68(1):5-21. doi: 10.1111/his.12876. Review.

2.

BRCA 1/2 gene mutation and gastrointestinal stromal tumours: a potential association.

Waisbren J, Uthe R, Siziopikou K, Kaklamani V.

BMJ Case Rep. 2015 Jul 6;2015. pii: bcr2014208830. doi: 10.1136/bcr-2014-208830.

3.

Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.

Schink JC, Trosman JR, Weldon CB, Siziopikou KP, Tsongalis GJ, Rademaker AW, Patel JD, Benson AB 3rd, Perez EA, Gradishar WJ.

J Natl Cancer Inst. 2014 Sep 12;106(10). pii: dju256. doi: 10.1093/jnci/dju256. Print 2014 Oct.

4.

Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing.

Xu Y, Gao XD, Lee JH, Huang H, Tan H, Ahn J, Reinke LM, Peter ME, Feng Y, Gius D, Siziopikou KP, Peng J, Xiao X, Cheng C.

Genes Dev. 2014 Jun 1;28(11):1191-203. doi: 10.1101/gad.241968.114. Epub 2014 May 19.

5.

Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.

Siziopikou KP, Anderson SJ, Cobleigh MA, Julian TB, Arthur DW, Zheng P, Mamounas EP, Pajon ER, Behrens RJ, Eakle JF, Leasure NC, Atkins JN, Polikoff JA, Seay TE, McCaskill-Stevens WJ, Rabinovitch R, Costantino JP, Wolmark N.

Breast Cancer Res Treat. 2013 Nov;142(2):415-21. doi: 10.1007/s10549-013-2755-z. Epub 2013 Nov 8.

6.

CD44 promotes Kras-dependent lung adenocarcinoma.

Zhao P, Damerow MS, Stern P, Liu AH, Sweet-Cordero A, Siziopikou K, Neilson JR, Sharp PA, Cheng C.

Oncogene. 2013 Oct 24;32(43):5186-90. doi: 10.1038/onc.2012.542. Epub 2012 Dec 3.

7.

The role of cancer stem cells in breast cancer initiation and progression: potential cancer stem cell-directed therapies.

Economopoulou P, Kaklamani VG, Siziopikou K.

Oncologist. 2012;17(11):1394-401. doi: 10.1634/theoncologist.2012-0163. Epub 2012 Aug 31. Review.

8.

Pathologic findings in MRI-guided needle core biopsies of the breast in patients with newly diagnosed breast cancer.

Siziopikou KP, Jokich P, Cobleigh M.

Int J Breast Cancer. 2011;2011:613285. doi: 10.4061/2011/613285. Epub 2010 Dec 1.

9.

The role of the fat mass and obesity associated gene (FTO) in breast cancer risk.

Kaklamani V, Yi N, Sadim M, Siziopikou K, Zhang K, Xu Y, Tofilon S, Agarwal S, Pasche B, Mantzoros C.

BMC Med Genet. 2011 Apr 13;12:52. doi: 10.1186/1471-2350-12-52.

10.

Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches.

Rizzo P, Miao H, D'Souza G, Osipo C, Song LL, Yun J, Zhao H, Mascarenhas J, Wyatt D, Antico G, Hao L, Yao K, Rajan P, Hicks C, Siziopikou K, Selvaggi S, Bashir A, Bhandari D, Marchese A, Lendahl U, Qin JZ, Tonetti DA, Albain K, Nickoloff BJ, Miele L.

Cancer Res. 2008 Jul 1;68(13):5226-35. doi: 10.1158/0008-5472.CAN-07-5744. Erratum in: Cancer Res. 2008 Sep 1;68(17):7246. Song, Lynda L [added].

Supplemental Content

Loading ...
Support Center